313 related articles for article (PubMed ID: 23381569)
1. De-SUMOylation enzyme of sentrin/SUMO-specific protease 2 regulates disturbed flow-induced SUMOylation of ERK5 and p53 that leads to endothelial dysfunction and atherosclerosis.
Heo KS; Chang E; Le NT; Cushman H; Yeh ET; Fujiwara K; Abe J
Circ Res; 2013 Mar; 112(6):911-23. PubMed ID: 23381569
[TBL] [Abstract][Full Text] [Related]
2. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells.
Woo CH; Shishido T; McClain C; Lim JH; Li JD; Yang J; Yan C; Abe J
Circ Res; 2008 Mar; 102(5):538-45. PubMed ID: 18218985
[TBL] [Abstract][Full Text] [Related]
3. Disturbed flow-activated p90RSK kinase accelerates atherosclerosis by inhibiting SENP2 function.
Heo KS; Le NT; Cushman HJ; Giancursio CJ; Chang E; Woo CH; Sullivan MA; Taunton J; Yeh ET; Fujiwara K; Abe J
J Clin Invest; 2015 Mar; 125(3):1299-310. PubMed ID: 25689261
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
Heo KS; Chang E; Takei Y; Le NT; Woo CH; Sullivan MA; Morrell C; Fujiwara K; Abe J
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):321-9. PubMed ID: 23202365
[TBL] [Abstract][Full Text] [Related]
5. Disturbed Flow-Induced Endothelial Proatherogenic Signaling Via Regulating Post-Translational Modifications and Epigenetic Events.
Heo KS; Berk BC; Abe J
Antioxid Redox Signal; 2016 Sep; 25(7):435-50. PubMed ID: 26714841
[TBL] [Abstract][Full Text] [Related]
6. Disturbed-flow-mediated vascular reactive oxygen species induce endothelial dysfunction.
Heo KS; Fujiwara K; Abe J
Circ J; 2011; 75(12):2722-30. PubMed ID: 22076424
[TBL] [Abstract][Full Text] [Related]
7. A crucial role for p90RSK-mediated reduction of ERK5 transcriptional activity in endothelial dysfunction and atherosclerosis.
Le NT; Heo KS; Takei Y; Lee H; Woo CH; Chang E; McClain C; Hurley C; Wang X; Li F; Xu H; Morrell C; Sullivan MA; Cohen MS; Serafimova IM; Taunton J; Fujiwara K; Abe J
Circulation; 2013 Jan; 127(4):486-99. PubMed ID: 23243209
[TBL] [Abstract][Full Text] [Related]
8. Endothelial activation and fibrotic changes are impeded by laminar flow-induced CHK1-SENP2 activity through mechanisms distinct from endothelial-to-mesenchymal cell transition.
Nguyen MTH; Imanishi M; Li S; Chau K; Banerjee P; Velatooru LR; Ko KA; Samanthapudi VSK; Gi YJ; Lee LL; Abe RJ; McBeath E; Deswal A; Lin SH; Palaskas NL; Dantzer R; Fujiwara K; Borchrdt MK; Turcios EB; Olmsted-Davis EA; Kotla S; Cooke JP; Wang G; Abe JI; Le NT
Front Cardiovasc Med; 2023; 10():1187490. PubMed ID: 37711550
[TBL] [Abstract][Full Text] [Related]
9. Laminar flow activation of ERK5 protein in vascular endothelium leads to atheroprotective effect via NF-E2-related factor 2 (Nrf2) activation.
Kim M; Kim S; Lim JH; Lee C; Choi HC; Woo CH
J Biol Chem; 2012 Nov; 287(48):40722-31. PubMed ID: 23043106
[TBL] [Abstract][Full Text] [Related]
10. PKCζ mediates disturbed flow-induced endothelial apoptosis via p53 SUMOylation.
Heo KS; Lee H; Nigro P; Thomas T; Le NT; Chang E; McClain C; Reinhart-King CA; King MR; Berk BC; Fujiwara K; Woo CH; Abe J
J Cell Biol; 2011 May; 193(5):867-84. PubMed ID: 21624955
[TBL] [Abstract][Full Text] [Related]
11. Effects of MEK5/ERK5 association on small ubiquitin-related modification of ERK5: implications for diabetic ventricular dysfunction after myocardial infarction.
Shishido T; Woo CH; Ding B; McClain C; Molina CA; Yan C; Yang J; Abe J
Circ Res; 2008 Jun; 102(11):1416-25. PubMed ID: 18467627
[TBL] [Abstract][Full Text] [Related]
12. ERK5/KLF2 activation is involved in the reducing effects of puerarin on monocyte adhesion to endothelial cells and atherosclerotic lesion in apolipoprotein E-deficient mice.
Deng Y; Lei T; Li H; Mo X; Wang Z; Ou H
Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2590-2599. PubMed ID: 29723698
[TBL] [Abstract][Full Text] [Related]
13. PKCzeta decreases eNOS protein stability via inhibitory phosphorylation of ERK5.
Nigro P; Abe J; Woo CH; Satoh K; McClain C; O'Dell MR; Lee H; Lim JH; Li JD; Heo KS; Fujiwara K; Berk BC
Blood; 2010 Sep; 116(11):1971-9. PubMed ID: 20538799
[TBL] [Abstract][Full Text] [Related]
14. Flow signaling and atherosclerosis.
Le NT; Sandhu UG; Quintana-Quezada RA; Hoang NM; Fujiwara K; Abe JI
Cell Mol Life Sci; 2017 May; 74(10):1835-1858. PubMed ID: 28039525
[TBL] [Abstract][Full Text] [Related]
15. Disturbed flow: p53 SUMOylation in the turnover of endothelial cells.
Takabe W; Alberts-Grill N; Jo H
J Cell Biol; 2011 May; 193(5):805-7. PubMed ID: 21624951
[TBL] [Abstract][Full Text] [Related]
16. SUMO-specific protease 2 in Mdm2-mediated regulation of p53.
Jiang M; Chiu SY; Hsu W
Cell Death Differ; 2011 Jun; 18(6):1005-15. PubMed ID: 21183956
[TBL] [Abstract][Full Text] [Related]
17. Erk5 inhibits endothelial migration via KLF2-dependent down-regulation of PAK1.
Komaravolu RK; Adam C; Moonen JR; Harmsen MC; Goebeler M; Schmidt M
Cardiovasc Res; 2015 Jan; 105(1):86-95. PubMed ID: 25388666
[TBL] [Abstract][Full Text] [Related]
18. Activation of GPR30 with G1 inhibits oscillatory shear stress-induced adhesion of THP-1 monocytes to HAECs by increasing KLF2.
Chen C; Chen J; Tao X; Fu M; Cheng B; Chen X
Aging (Albany NY); 2021 Apr; 13(8):11942-11953. PubMed ID: 33875621
[TBL] [Abstract][Full Text] [Related]
19. The SUMO-specific protease SENP1 deSUMOylates p53 and regulates its activity.
Chauhan KM; Chen Y; Chen Y; Liu AT; Sun XX; Dai MS
J Cell Biochem; 2021 Feb; 122(2):189-197. PubMed ID: 32786121
[TBL] [Abstract][Full Text] [Related]
20. SUMOylation Is Required for ERK5 Nuclear Translocation and ERK5-Mediated Cancer Cell Proliferation.
Erazo T; Espinosa-Gil S; Diéguez-Martínez N; Gómez N; Lizcano JM
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32209980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
